First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis

First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis / Ghia, P., Owen, C., Allan, J.N., Barrientos, J.C., Barr, P.M., Shi, C., Szoke, A., Abbazio, C., Krigsfeld, G.S., Burger, J.A.. - In: HEMASPHERE. - ISSN 2572-9241. - 8:5(2024). [10.1002/hem3.74]